Literature DB >> 17630917

Brachytherapy: state of the art and possible improvements.

S Buono1, N Burgio, M Hamoudeh, H Fessi, E Hiltbrand, L Maciocco, S Mehier-Humbert.   

Abstract

Cancer often remains an incurable disease, despite significant progresses in diagnosis and treatment that have been made. Specifically, the use of nuclear medicine in oncology is greatly contributing to both imaging and therapy aspects. Targeted therapies are a major field of interest since it increases efficiency and reduces side effects. Brachytherapy is among the most valuable of recent developments for treating localized tumours resulting in improvements in improved quality of life. This is primarily because it irradiates cancerous cells most exclusively while barely effecting healthy tissue. The use of radiochemicals implies specific management for production, transport and handling that have limited the development of this technique. This review article describes brachytherapy and their latest developments. Furthermore, alternative activation methods for the production of radioisotopes and a novel delivery system for targeted multi-therapy by using PLA-ferrite nanospheres are described.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17630917     DOI: 10.2174/187152007781058640

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  2 in total

1.  Biodegradable seeds of holmium don't change neurological function after implant in brain of rats.

Authors:  Mirla Fiuza Diniz; Diogo Milioli Ferreira; Wanderson Geraldo de Lima; Maria Lucia Pedrosa; Marcelo Eustáquio Silva; Stanley de Almeida Araujo; Kinulpe Honorato Sampaio; Tarcisio Passos Ribeiro de Campos; Savio Lana Siqueira
Journal:  Rep Pract Oncol Radiother       Date:  2017-05-11

2.  Intraoperative imaging guidance for sentinel node biopsy in melanoma using a mobile gamma camera.

Authors:  Lynn T Dengel; Mitali J More; Patricia G Judy; Gina R Petroni; Mark E Smolkin; Patrice K Rehm; Stan Majewski; Mark B Williams; Craig L Slingluff
Journal:  Ann Surg       Date:  2011-04       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.